Hawthorne Medical Research, Inc.

Winston-Salem, North Carolina 27103

0 studies enrolling now · 19 studies all time

What they study most

Candidiasis, Vulvovaginal, Contraception, Dyspareunia, Endometrial Biopsy, Genital Herpes, Hot Flashes, Menopause, Metrorrhagia, Moniliasis, Vulvovaginal, Mycoses, Overactive Bladder, Postmenopausal Symptoms

Studies at this site

• Evaluate Long-Term Safety and Efficacy WC3011 (Estradiol Vaginal Cream) — Completed
• Safety & Efficacy WC3011 (Estradiol Vaginal Cream) in the Treatment of Vulvovaginal Atrophy in Postmenopausal Women — Completed
• RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections — Completed
• Safety, Efficacy, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 Cycles — Completed
• Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization — Completed
• A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy — Completed
• COL-1077 (Lidocaine Bioadhesive Gel, 10%) in Women Undergoing Transvaginal Pipelle-Directed Endometrial Biopsy — Completed
• Safety and Efficacy Study of AR08 for the Treatment of Vasomotor Symptoms (VMS) — Stopped early
• Efficacy/Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms (VMS) — Completed
• Eight-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms Associated With Menopause — Completed
• 24-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms — Completed
• Multicenter Study Evaluating the Safety of Proellex® in Premenopausal Women With Uterine Fibroids — Stopped early
• Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms — Withdrawn before enrolling
• A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine — Completed
• Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding — Completed
• Vaginal Infection Study — Completed
• Safety and Efficacy of PP4001 for the Treatment of Symptoms Associated With Uncomplicated Urinary Tract Infection — Completed
• Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes — Completed
• Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black Patients — Completed